How do regulatory networks decode X-chromosomal dosage information to control X inactivation and stem cell differentiation?
Edda Schulz, Max Planck Institute for Molecular Genetics, Berlin
14:00 - Small Operon
Precision and Plasticity in Animal Transcription
Angela DePace, Harvard Medical School, Systems Biology Department,
09:30 - Small Operon
EMBL Ventures manages multi-million euro capital on behalf of private and industrial investors in Europe, including EMBL.More Information